Astaxanthin as a potential therapeutic agent in polycystic ovary syndrome: a review of its antioxidant, anti-inflammatory, and metabolic mechanisms - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Astaxanthin's Role as a Potential Treatment for Polycystic Ovary Syndrome: An Overview of Its Antioxidant, Anti-Inflammatory, and Metabolic Effects

  • By

  • Jialai Wang

  • Ying Yang

  • Ziwei Wang

  • Chengdong Liu

  • Yanhua Han

  • Xiaoke Wu

  • Hui Chang

  • July 13, 2026

Share

Original Source(s)

Astaxanthin as a potential therapeutic agent in polycystic ovary syndrome: a review of its antioxidant, anti-inflammatory, and metabolic mechanisms

  • by Jialai Wang, Ying Yang, Ziwei Wang, Chengdong Liu, Yanhua Han, Xiaoke Wu, Hui Chang

  • July 13, 2026

Related Content

Identification of predictors of the ovarian response to clomiphene citrate in infertile women with polycystic ovary syndrome: A post-hoc analysis of a randomized controlled trial

Combined metabolic-reproductive association and predictive value of AMH and TyG index in PCOS: a single-center retrospective study

Adjunctive berberine improves hormonal, metabolic, and inflammatory profiles in women with polycystic ovary syndrome: a retrospective case–control study